4-Amino-1-(3,4-dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-vinyl-1H-pyrimidin-2-one

ID: ALA3350548

Cas Number: 216450-09-8

PubChem CID: 54437788

Max Phase: Preclinical

Molecular Formula: C11H15N3O4

Molecular Weight: 253.26

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c(=O)nc1N

Standard InChI:  InChI=1S/C11H15N3O4/c1-3-6-4-14(11(17)13-9(6)12)10-8(16)7(15)5(2)18-10/h3-5,7-8,10,15-16H,1H2,2H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1

Standard InChI Key:  WLXYZJRKLHXRBP-VPCXQMTMSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    6.6369   -2.1072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8523   -2.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5931   -1.0452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8085   -1.3002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2500   -2.6592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0347   -2.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1849   -1.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2062   -1.5973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5974   -3.1467    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5175   -2.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7724   -3.1467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6478   -2.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1954   -0.7482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9908   -1.3423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1849   -1.0522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4324   -2.7013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7328   -2.1072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -3.8142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  3  4  1  0
  4  1  1  0
  5  1  1  0
  6  5  2  0
  7  2  1  0
  8  6  1  0
  9  2  1  0
 10  7  1  0
 11  9  1  0
 12  6  1  0
 13  4  2  0
 14  8  1  0
  7 15  1  1
 16 12  2  0
 10 17  1  1
 11 18  1  6
  3  8  2  0
 11 10  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

CDA Tclin Cytidine deaminase (97 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 253.26Molecular Weight (Monoisotopic): 253.1063AlogP: -0.89#Rotatable Bonds: 2
Polar Surface Area: 110.60Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.59CX Basic pKa: CX LogP: -1.21CX LogD: -1.21
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.63Np Likeness Score: 1.42

References

1. Hattori K, Kohchi Y, Oikawa N, Suda H, Ura M, Ishikawa T, Miwa M, Endoh M, Eda H, Tanimura H, Kawashima A, Horii I, Ishitsuka H, Shimma N..  (2003)  Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.,  13  (5): [PMID:12617910] [10.1016/s0960-894x(02)01082-x]

Source